UBS Group AG - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 43 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
UBS Group AG ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$5,000
-28.6%
6,000
-25.0%
0.00%
Q2 2022$7,0000.0%8,0000.0%0.00%
Q1 2022$7,0000.0%8,0000.0%0.00%
Q4 2021$7,000
-50.0%
8,000
-46.7%
0.00%
Q3 2021$14,000
-17.6%
15,000
-16.7%
0.00%
Q2 2021$17,000
+30.8%
18,000
+28.6%
0.00%
Q1 2021$13,000
+62.5%
14,000
+75.0%
0.00%
Q4 2020$8,0008,0000.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Opti Capital Management, LP 42,313,000$37,738,0003.63%
DeepCurrents Investment Group LLC 78,898,000$69,839,0002.79%
STEELHEAD PARTNERS LLC 31,350,000$27,716,0002.38%
Sonora Investment Management Group, LLC 20,200,000$17,734,0001.68%
Penn Mutual Asset Management, LLC 1,256,000$1,103,0001.49%
TENOR CAPITAL MANAGEMENT Co., L.P. 64,271,000$57,050,0001.28%
CAMDEN ASSET MANAGEMENT L P /CA 21,346,000$18,752,0000.58%
AVIVA PLC 60,265,000$52,901,0000.28%
OAKTREE CAPITAL MANAGEMENT LP 24,313,000$21,480,0000.25%
ADVENT CAPITAL MANAGEMENT /DE/ 13,680,000$12,086,0000.21%
View complete list of IONIS PHARMACEUTICALS INC shareholders